These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26620820)

  • 1. Low dose cyclophosphamide: Mechanisms of T cell modulation.
    Madondo MT; Quinn M; Plebanski M
    Cancer Treat Rev; 2016 Jan; 42():3-9. PubMed ID: 26620820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis.
    Dimeloe S; Frick C; Fischer M; Gubser PM; Razik L; Bantug GR; Ravon M; Langenkamp A; Hess C
    Eur J Immunol; 2014 Dec; 44(12):3614-20. PubMed ID: 25251877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed.
    Abu Eid R; Razavi GS; Mkrtichyan M; Janik J; Khleif SN
    Cancer Immunol Res; 2016 May; 4(5):377-82. PubMed ID: 27196429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.
    Zhao J; Cao Y; Lei Z; Yang Z; Zhang B; Huang B
    Cancer Res; 2010 Jun; 70(12):4850-8. PubMed ID: 20501849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of cyclophosphamide and ifosfamide pharmacology.
    Fleming RA
    Pharmacotherapy; 1997; 17(5 Pt 2):146S-154S. PubMed ID: 9322882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide induces differentiation of Th17 cells in cancer patients.
    Viaud S; Flament C; Zoubir M; Pautier P; LeCesne A; Ribrag V; Soria JC; Marty V; Vielh P; Robert C; Chaput N; Zitvogel L
    Cancer Res; 2011 Feb; 71(3):661-5. PubMed ID: 21148486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer model.
    Son CH; Shin DY; Kim SD; Park HS; Jung MH; Bae JH; Kang CD; Yang K; Park YS
    J Immunother; 2012 Oct; 35(8):607-14. PubMed ID: 22996366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunomodulatory effects of toceranib combined with low-dose cyclophosphamide in dogs with cancer.
    Mitchell L; Thamm DH; Biller BJ
    J Vet Intern Med; 2012; 26(2):355-62. PubMed ID: 22303814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
    del Olmo M; Alonso-Varona A; Castro B; Calle Y; Bilbao P; Palomares T
    Melanoma Res; 2000 Apr; 10(2):103-12. PubMed ID: 10803710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer.
    Wagner A; Hempel G; Boos J
    Anticancer Drugs; 1997 Jun; 8(5):419-31. PubMed ID: 9215603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
    Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
    Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose cyclophosphamide-mediated anti-tumor effects by the superior expansion of CD44(high) cells after their selective depletion.
    Hong SH; Yoon IH; Kim YH; Yang SH; Park MJ; Nam HY; Kim B; Kim Y; Park CS; Park CG
    Immunobiology; 2010 Mar; 215(3):182-93. PubMed ID: 19464751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization.
    Barbon CM; Yang M; Wands GD; Ramesh R; Slusher BS; Hedley ML; Luby TM
    Cell Immunol; 2010; 262(2):150-61. PubMed ID: 20206921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy.
    Ahlmann M; Hempel G
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):661-71. PubMed ID: 27646791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.
    Ghiringhelli F; Larmonier N; Schmitt E; Parcellier A; Cathelin D; Garrido C; Chauffert B; Solary E; Bonnotte B; Martin F
    Eur J Immunol; 2004 Feb; 34(2):336-44. PubMed ID: 14768038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model.
    Rico MJ; Rozados VR; Mainetti LE; Zacarias Fluck MF; Matar P; Scharovsky OG
    Exp Oncol; 2012; 34(1):38-42. PubMed ID: 22453147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained P450 expression and prodrug activation in bolus cyclophosphamide-treated cultured tumor cells. Impact of prodrug schedule on P450 gene-directed enzyme prodrug therapy.
    Schwartz PS; Chen CS; Waxman DJ
    Cancer Gene Ther; 2003 Aug; 10(8):571-82. PubMed ID: 12872138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomide.
    Ding Q; Kestell P; Baguley BC; Palmer BD; Paxton JW; Muller G; Ching LM
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):186-92. PubMed ID: 12203100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
    Chen L; Waxman DJ; Chen D; Kufe DW
    Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.